New perspectives on innovative drug discovery: an overview.

Despite advances in technology, drug discovery is still a lengthy, expensive, difficult, and inefficient process, with a low rate of success. Today, advances in biomedical science have brought about great strides in therapeutic interventions for a wide spectrum of diseases. The advent of biochemical techniques and cutting-edge bio/chemical technologies has made available a plethora of practical approaches to drug screening and design. In 2010, the total sales of the global pharmaceutical market will reach 600 billion US dollars and expand to over 975 billion dollars by 2013. The aim of this review is to summarize available information on contemporary approaches and strategies in the discovery of novel therapeutic agents, especially from the complementary and alternative medicines, including natural products and traditional remedies such as Chinese herbal medicine.

• Publication year

  2010

• Venue

  Journal of Pharmacy & Pharmaceutical Sciences

• Publication date

  2010-11-08

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.18433/J39W2GPMID 21092716
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Soy isoflavones.

  2020cited by this paper
• Are the economics of pharmaceutical research and development changing?

  2012cited by this paper
• New Perspectives on Chinese Herbal Medicine (Zhong-Yao) Research and Development

  2011influential reference
• Ethanol Extract of Fructus Schisandrae Decreases Hepatic Triglyceride Level in Mice Fed with a High Fat/Cholesterol Diet, with Attention to Acute Toxicity

  2011cited by this paper
• Resveratrol protects against methotrexate-induced hepatic injury in rats.

  2010cited by this paper
• The two faces of pharmacokinetics.

  2010cited by this paper
• Angiotensin-I-Converting Enzyme (ACE) Inhibitors from Marine Resources: Prospects in the Pharmaceutical Industry

  2010cited by this paper
• Anti-photoaging and Photoprotective Compounds Derived from Marine Organisms

  2010cited by this paper
• Evaluation of the protective effects of quercetin, rutin, naringenin, resveratrol and trolox against idarubicin-induced DNA damage.

  2010cited by this paper
• Stability of Protein Pharmaceuticals: An Update

  2010cited by this paper
• Once-a-day administration of everolimus, cyclosporine, and steroid after renal transplantation: a review of the rationale.

  2010cited by this paper
• Compliance With the Treatment of Hypertension: The Potential of Combination Therapy

  2010cited by this paper
• Prediction of protein–ligand binding affinity by free energy simulations: assumptions, pitfalls and expectations

  2010cited by this paper
• The promise of slow down ageing may come from curcumin.

  2010cited by this paper
• Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders

  2010cited by this paper
• The role of p53 in apoptosis.

  2010cited by this paper
• Personalized medicine in oncology: the future is now

  2010cited by this paper
• The hormetic role of dietary antioxidants in free radical-related diseases.

  2010cited by this paper
• Obesity and the human microbiome

  2010cited by this paper
• Immunization therapy for Alzheimer disease: a comprehensive review of active immunization strategies.

  2010cited by this paper
• Electrophiles in Foods: The Current Status of Isothiocyanates and Their Chemical Biology

  2010cited by this paper
• Phytochemical informatics and virtual screening of herbs used in Chinese medicine.

  2010cited by this paper
• Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome

  2010cited by this paper
• Personalizing medicine for cancer: the next decade

  2010cited by this paper
• Management of antibiotic resistance in the intensive care unit setting

  2010influential reference
• Ginkgo biloba and ginkgotoxin.

  2010influential reference
• Anticancer agents against malaria: time to revisit?

  2010cited by this paper
• Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications.

  2010cited by this paper
• Autobionics: a new paradigm in regenerative medicine and surgery.

  2010cited by this paper
• Voluntary exploratory data submissions to the US FDA and the EMA: experience and impact

  2010cited by this paper
• Therapeutic potential of peptide motifs - part III.

  2010cited by this paper
• Structure-based discovery of natural-product-like TNF-α inhibitors.

  2010cited by this paper
• Titration of Inhaled Human Insulin (Exubera) in a Treat-to-Target Regimen for Patients with Type 2 Diabetes

  2010cited by this paper
• Generation of stable cell lines by site-specific integration of transgenes into engineered Chinese hamster ovary strains using an FLP-FRT system.

  2010cited by this paper
• Molecular Targets of Dietary Phenethyl Isothiocyanate and Sulforaphane for Cancer Chemoprevention

  2010cited by this paper
• A systematic review and meta‐analysis on the therapeutic equivalence of statins

  2010cited by this paper
• How to improve R&D productivity: the pharmaceutical industry's grand challenge

  2010cited by this paper
• Lactobacillus rhamnosus GG influences polyamine metabolism in HGC-27 gastric cancer cell line: a strategy toward nutritional approach to chemoprevention of gastric cance.

  2010cited by this paper
• Resveratrol as a Therapeutic Agent for Neurodegenerative Diseases

  2010cited by this paper
• Malaria drugs: clues from malaria resistance genetics

  2009cited by this paper
• Panning for chemical gold: marine bacteria as a source of new therapeutics.

  2009cited by this paper
• Lycopene, an antioxidant carotenoid, attenuates testicular injury caused by ischemia/reperfusion in rats.

  2009cited by this paper
• Arbutin content and antioxidant activity of some Ericaceae species.

  2009cited by this paper
• Arsenic: a beneficial therapeutic poison - a historical overview.

  2009cited by this paper
• Developing technologies in biodefense research: computational drug design

  2009cited by this paper
• Recombinant activated factor VII for massive hemoptysis in patients with cystic fibrosis.

  2009cited by this paper
• Live cell imaging for target and drug discovery.

  2009cited by this paper
• Role of Huperzine a in the Treatment of Alzheimer's Disease

  2009cited by this paper
• From off-label prescribing towards a new FDA.

  2009cited by this paper
• Casein-derived tripeptide, Val-Pro-Pro (VPP), modulates monocyte adhesion to vascular endothelium.

  2009cited by this paper
• Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease.

  2009cited by this paper
• [Efficacy of arsenic trioxide for acute promyelocytic leukemia: a systematic review and meta-analysis].

  2009cited by this paper
• Bicyclol: a novel drug for treating chronic viral hepatitis B and C.

  2009influential reference
• Pharmaceutical product development technologies based on the biopharmaceutical classification system.

  2009cited by this paper
• Genetic and epigenetic regulations of prostate cancer by genistein.

  2009cited by this paper
• Drug development from marine natural products

  2009cited by this paper
• Trends in microbial synthesis of natural products and biofuels.

  2009cited by this paper
• Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy.

  2009cited by this paper
• The year's new drugs & biologics - 2008.

  2009cited by this paper
• Plant food-derived Angiotensin I converting enzyme inhibitory peptides.

  2009cited by this paper
• Finding value in the U.S. Food and Drug Administration's Fast Track program.

  2009cited by this paper
• Marine natural products.

  2009cited by this paper
• The efficacy of arsenic trioxide for the treatment of relapsed and refractory multiple myeloma: a systematic review.

  2009cited by this paper
• G-protein-coupled receptor-focused drug discovery using a target class platform approach.

  2009cited by this paper
• Can ginkgo biloba combat diseases?

  2009influential reference
• Protective effect of tomato against adrenaline-induced myocardial infarction in rats.

  2009cited by this paper
• Modelling and PBPK Simulation in Drug Discovery

  2009cited by this paper
• Discovery, mechanisms of action and combination therapy of artemisinin

  2009cited by this paper
• Lessons from 60 years of pharmaceutical innovation

  2009influential reference
• [Research advances of Huperzia serrata (Thunb.) Trev].

  2009cited by this paper
• Clinical and cosmeceutical uses of hydroxyacids.

  2009cited by this paper
• Medicinal chemistry of paclitaxel and its analogues.

  2009cited by this paper
• The intestinal environment in health and disease - recent insights on the potential of intestinal bacteria to influence human health.

  2009cited by this paper
• Antibiotics for Emerging Pathogens

  2009influential reference
• Therapeutic potential of peptide motifs--part II.

  2009cited by this paper
• Arsenic trioxide as first-line treatment for acute promyelocytic leukemia.

  2009cited by this paper
• Clinical trial design for adenoviral gene therapy products.

  2009cited by this paper
• Bixin regulates mRNA expression involved in adipogenesis and enhances insulin sensitivity in 3T3-L1 adipocytes through PPARgamma activation.

  2009cited by this paper
• Early toxicity screening strategies.

  2009cited by this paper
• Insertional mutagenesis and development of malignancies induced by integrating gene delivery systems: implications for the design of safer gene-based interventions in patients.

  2009cited by this paper
• Distribution and biological activities of the flavonoid luteolin.

  2009cited by this paper
• CDA-II, a urinary preparation, induces growth arrest and apoptosis of human leukemia cells through inactivation of nuclear factor-kappaB in a caspase-dependent manner.

  2009cited by this paper
• Erythropoiesis stimulating agents and techniques: a challenge for doping analysts.

  2009cited by this paper
• Promoting, improving and accelerating the drug development and approval processes.

  2009cited by this paper
• Curcumin has bright prospects for the treatment of inflammatory bowel disease.

  2009cited by this paper
• Evaluation of the in vitro anticancer, antimicrobial and antioxidant activities of some Yemeni plants used in folk medicine.

  2009cited by this paper
• Inhibitory effect of bionic fungicide 2-allylphenol on Botrytis cinerea (Pers. ex Fr.) in vitro.

  2009cited by this paper
• Food and therapeutic product interactions - a therapeutic perspective.

  2009cited by this paper
• Microbial antitumor drugs: natural products of microbial origin as anticancer agents.

  2009cited by this paper
• Synthesis and biological activity of Wuweizisu C and analogs.

  2009cited by this paper
• Natural products in drug discovery: present status and perspectives.

  2009cited by this paper
• Discovery and development of the anticancer agent salinosporamide A (NPI-0052).

  2009cited by this paper
• The value of drug repositioning in the current pharmaceutical market.

  2009cited by this paper
• Minocycline as a potential therapeutic agent in neurodegenerative disorders characterized by protein misfolding

  2009cited by this paper
• Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells

  2009cited by this paper
• Gene therapy approaches to induce tolerance in autoimmunity by reshaping the immune system.

  2009cited by this paper
• Antimalarials and the fight against malaria in Brazil

  2009cited by this paper
• Controlling Off-Label Medication Use

  2009influential reference
• Subcutaneous histamine versus botulinum toxin type A in migraine prophylaxis: a randomized, double‐blind study

  2009cited by this paper
• Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice.

  2008cited by this paper

• Bioactive potential of mediterranean macroalgae: comparative insights from the extracts of native (Ericaria brachycarpa and Ericaria crinita) and invasive (Asparagopsis taxiformis) species

  2026cites this paper
• Herbal Medicines: The Double-Edged Sword for Brain—A Narrative Update

  2025cites this paper
• Volatile Organic Compound Profiling of Traditional Multi-Herbal Prescriptions for Chemical Differentiation and Ethnopharmacological Insights

  2025cites this paper
• The activity of a herbal medicinal product of Phyllanthus niruri and Silybum marianum powdered extracts (Heptex®) in patients with apparent risk factors for nonalcoholic steatohepatitis: a phase II, multicentered, randomized, double-blind, placebo-controlled clinical trial

  2025cites this paper
• Physicochemical Characteristics, Antioxidant Capacity, Bioactive Compounds, and Microbial Stability of Saffron-Based Functional Beverage Stored in Glass Bottles With and Without Secondary Packaging at Ambient Conditions

  2025cites this paper
• Diversity oriented clicking for modular synthesis

  2025cites this paper
• Hydrogel-based drug delivery systems - a review

  2024cites this paper
• A Comprehensive Review of Antimicrobial Agents Against Clinically Important Bacterial Pathogens: Prospects for Phytochemicals

  2024cites this paper
• Benefits of Plants to Humans and Urban Ecosystems

  2023cites this paper
• Health-Promoting Effects of Bioactive Compounds from Plant Endophytic Fungi

  2023cites this paper
• Functional Metagenomics as a Tool to Tap into Natural Diversity of Valuable Biotechnological Compounds.

  2023cites this paper
• Network Pharmacology Approach for Medicinal Plants: Review and Assessment

  2022cites this paper
• A Phase II, Randomized, Double-Blind, Double-Dummy, Active-Controlled Clinical Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients Newly Diagnosed with Type 2 Diabetes Mellitus

  2022cites this paper
• Low-Glu® in Patients Newly Diagnosed with Type 2 Diabetes Mellitus

  2022cites this paper
• Opportunities for the discovery of anticancer drugs from traditional herbal medicines in Africa: A Review

  2022cites this paper
• Plants and phytochemicals inhibit scar formation: A systematic review

  2022cites this paper
• Black Velvet Tamarind: Phytochemical Analysis, Antiradical and Antimicrobial Properties of the Seed Extract for Human Therapeutic and Health Benefits

  2021cites this paper
• Exploitation of revered potent medicinal mushroom Ganoderma lucidum with particular accent on oncotherapeutics

  2021cites this paper
• Endophytic Microbial Diversity: A New Hope for the Production of Novel Anti-tumor and Anti-HIV Agents as Future Therapeutics

  2021cites this paper
• Medical and pharmacokinetic effects of nanopolyphenols: A systematic review of clinical trials

  2021cites this paper
• Nanomedicine based approaches for combating viral infections.

  2021cites this paper
• Protective Effect of Pyxinol, One Active Ingredient of Lichenes on Cisplatin-Induced Nephrotoxicity via Ameliorating DNA Damage Response

  2021cites this paper
• Medicinal plants used in the treatment of Malaria: A key emphasis to Artemisia, Cinchona, Cryptolepis, and Tabebuia genera

  2020cites this paper
• Novel Antibacterial Strategies for Combating Bacterial Multidrug Resistance.

  2020cites this paper
• Calotropis - A multi-potential plant to humankind: Special focus on its wound healing efficacy

  2020cites this paper
• Milk colloidal system as a reaction medium and carrier for the natural blue colorant obtained from the cross-linking between genipin and milk proteins

  2020cites this paper
• Identifying Plant-Based Natural Medicine against Oxidative Stress and Neurodegenerative Disorders

  2020cites this paper
• Constituintes voláteis de diferentes órgãos vegetais de Piper aduncum L

  2020cites this paper
• Antioxidative properties of spices and their impact on postprandial blood glucose in humans

  2019cites this paper
• Animal Models of Inflammation for Screening of Anti-inflammatory Drugs: Implications for the Discovery and Development of Phytopharmaceuticals

  2019cites this paper
• Caffeic acid has antipromastigote activity by apoptosis-like process; and anti-amastigote by TNF-α/ROS/NO production and decreased of iron availability.

  2019cites this paper
• Natural Products Solution against Superbugs: A Challenge of Biodiversity in a Public Health Issue

  2018cites this paper
• Modulation of Oxidative Stress and Hyperglycemia by Rheum spiciformis in Alloxan Induced Diabetic Rats and Characterization of Isolated Compound

  2018cites this paper
• Sustainable Utilization of Medicinal Plants of Ladakh and Lahaul-Spiti of Trans-Himalaya

  2018cites this paper
• A Meta-Analysis of the Efficacy of Panax Ginseng on Menopausal Women’s Sexual Function

  2018cites this paper
• Pentacyclic triterpenoids: Discovery of new drugs with antitumour activity

  2017cites this paper
• Screening for bioactivity of Mutinus elegans extracts

  2017cites this paper
• Medicinal Plants: Ethno-Uses to Biotechnology Era

  2017cites this paper
• TLC Analysis and GC-MS Profiling of Hexane Extract of Syzygium guineense Leaf

  2016cites this paper
• Antimicrobial Adjuvants Drug Discovery, the Challenge of Avoid theResistance and Recover the Susceptibility of Multidrug-Resistant Strains

  2016cites this paper
• Breakthroughs in bacterial resistance mechanisms and the potential ways to combat them.

  2016cites this paper
• Novel Anti-inflammatory Drugs from Marine Microbes

  2015cites this paper
• Therapeutic switching: from antidermatophytic essential oils to new leishmanicidal products

  2015cites this paper
• Bioactive Secondary Metabolites from Culturable Unusual Actinomycetes from Solomon Islands Marine Sediments: Isolation and Characterisation of Bioactive Compounds

  2015influential citation
• An Improved Method for P2X7R Antagonist Screening

  2015cites this paper
• The protective effects of Schisandra chinensis fruit extract and its lignans against cardiovascular disease: a review of the molecular mechanisms.

  2014cites this paper
• Evaluating protein-protein interaction (PPI) networks for diseases pathway, target discovery, and drug-design using 'in silico pharmacology'.

  2014cites this paper
• Impact of Microbial Natural Products on Antibacterial Drug Discovery

  2013cites this paper
• Comparative Study on In Vitro Activities of Citral, Limonene and Essential Oils from Lippia citriodora and L. alba on Yellow Fever Virus

  2013cites this paper
• Bioactive metabolites from macrofungi: ethnopharmacology, biological activities and chemistry

  2013cites this paper
• The creation and interpretation of an elemental database for Chinese traditional herbal remedies

  2013cites this paper
• Integrative Systems Approaches Towards Brain Pharmacology and Polypharmacology

  2013cites this paper
• Molecules of natural origin, semi-synthesis and synthesis with anti-inflammatory and anticancer utilities.

  2012cites this paper
• DESARROLLO DE UN MÉTODO RÁPIDO MEDIANTE CROMATOGRAFÍA DE CAPA FINA (CCF) QUE PERMITA LA CUANTIFICACIÓN DE METABOLITOS SECUNDARIOS EN EXTRACTOS DE PLANTAS.

  2012cites this paper
• Drug Repositioning: A Faster Path to Drug Discovery

  2012cites this paper
• New perspectives on complementary and alternative medicine: an overview and alternative therapy.

  2012cites this paper
• Novel models for assessing blood–brain barrier drug permeation

  2012cites this paper
• ETUDE DE SUBSTANCES BIOACTIVES ISSUES DE LA FLORE AMAZONIENNE Analyse de préparations phytothérapeutiques à base de Quassia amara L. (Simaroubaceae) et de Psidium acutangulum DC. (Myrtaceae) utilisées en Guyane française pour une indication antipaludique. Identification et analyse métabolomique d'hu

  2011cites this paper
• Digital Commons @ University of South Florida Digital Commons @ University of South Florida

  year unknowncites this paper